CFDE Data Portal | Search LINC01558

	Label	Description
	LINC01558 Gene (Entity type)	ENSG00000198221 - long intergenic non-protein coding RNA 1558
	GSE115384 CELSR2 knockdown 5 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE225901 dexamethasone 2 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE136414 hydroxyl 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE193838 catechin 0 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE218060 decitabine T cell 7 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE193838 catechin 0 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE149768 hypoxanthine 2 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE235701 GSE261434 enasidenib 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE229973 cisplatin 4 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS

LINC01558

ENSG00000198221 - long intergenic non-protein coding RNA 1558

GSE115384 CELSR2 knockdown 5 v 1 human dn

A Gene Set from LINCS

GSE225901 dexamethasone 2 v 3 human dn

A Gene Set from LINCS

GSE136414 hydroxyl 1 v 2 human dn

A Gene Set from LINCS

GSE193838 catechin 0 v 2 human dn

A Gene Set from LINCS

GSE218060 decitabine T cell 7 v 0 human dn

A Gene Set from LINCS

GSE193838 catechin 0 v 4 human dn

A Gene Set from LINCS

GSE149768 hypoxanthine 2 v 4 human up

A Gene Set from LINCS

GSE235701 GSE261434 enasidenib 2 v 1 human dn

A Gene Set from LINCS

GSE229973 cisplatin 4 v 2 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.